Seema Kumar is CEO of Cure, a health care innovation campus in New York City. Prior to Cure, Kumar spent nearly 20 years at Johnson & Johnson in senior leadership roles, including as global head of the Office of Innovation, Global Health and Scientific Engagement, and served on J&J’s innovation strategy and public health leadership and COVID-19 vaccine steering committee, leading the company’s external affairs efforts and public education program on COVID and vaccine literacy. Earlier, Kumar was chief of staff to Eric Lander and chief communications officer at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research where she played a leadership role in the Human Genome Project. She has held leadership positions at the National Institute of Allergy and Infectious Diseases, National Institutes of Health and Johns Hopkins School of Medicine.